Home/Filings/4/0000950170-23-045467
4//SEC Filing

Weill David 4

Accession 0000950170-23-045467

CIK 0001756262other

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 4:33 PM ET

Size

4.9 KB

Accession

0000950170-23-045467

Insider Transaction Report

Form 4
Period: 2023-08-29
Weill David
Director
Transactions
  • Purchase

    Common Stock

    2023-08-29$62.00/sh+2,500$155,00013,693 total
Footnotes (2)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $61.98 to $62.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  • [F2]Includes 1,193 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001774270

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 4:33 PM ET
Size
4.9 KB